Leukotrienes do not regulate nitric oxide production in RAW 264.7 macrophages

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 3, 1996, Pages 145-149

  Hulkower, K I ^a   Pollock, J S ^a   Walsh, R E ^a   Huang, R ^a   Otis, E R ^a   Brooks, C D W ^a   Bell, R L ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 [5 (4 FLUOROPHENOXY) 2 FURYL] 1 METHYL 2 PROPYNYL] 1 HYDROXYUREA; CALCIMYCIN; DEXAMETHASONE; GAMMA INTERFERON; LEUKOTRIENE; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; LIPOXYGENASE INHIBITOR; NITRIC OXIDE; NORDIHYDROGUAIARETIC ACID; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; SIGANUS;

EID: 0029862827     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90089-7     Document Type: Article

References (11)

1. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
2. Xie W., Robertson D. L., Simmons D. L. Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs. Drug Dev Res 1992; 25: 249-265.
3. Salvemini D., Misko T. P., Masferrer J. L., Seibert K., Currie M. G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90: 7240-7244.
4. Corbett J. A., Kwon G., Turk J., McDaniel M. L., IL-1βinduces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: Activation of cyclooxygenase by nitric oxide. Biochemistry 1993; 32: 13767-13770.
5. Nathan C. F. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
6. Ford-Hutchinson A. W., Gresser M., Young R. N. 5-Lipoxygenase. Annu Rev Biochem 1994; 63: 383-417.
7. Imai Y., Kolb H., Burkart V. Nitric oxide production from macrophages is regulated by arachidonic acid metabolites. Biochem Biophys Res Commun 1993; 197: 105-109.
8. Bell R. L., Bouska J. B., Malo P. E., et al. Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors. J Pharmacol Exp Ther 1995; 272: 724-731.
9. 2. J Rheumatol 1991; 18: 59-65.
10. 4 biosynthesis in the human neutrophil: Effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase. Agents Actions 1991; 34: 89-92.
11. Wood J. N., Coote P. R., Salmon J., Rhodes J. A small phospholipase inhibitory factor released by culture cell lines. FEBS Lett 1985; 189: 202-206.